Basic Information
Basic information for C21orf62-AS1-213-31aa-2
Peptide Name C21orf62-AS1-213-31aa-2
Genome Position chr21:32801908-32802000[+]
Species Human
Peptide Sequence MCSLGQAEKRFGLGRARQCRYKSHWRRCQND
Peptide Length 31
Unique Yes
Grand Average of Hydropathicity -1.3097
Relative Molecular Mass 4282.74
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000669746;C21orf62-AS1-213
Transcript Length 1704
Coding Ability 0.3674
DNA Sequence Corresponding to Peptide ATGTGCTCTTTGGGCCAGGCAGAGAAGAGGTTCGGGTTAGGAAGGGCGAGGCAGTGCAGATATAAGAGTCATTGGCGCAGATGTCAGAATGAC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :